Gilead Sciences Inc (GILD)

GILD (NASDAQ:Drugs)
$100.60
pos +0.02
+0.02%
Today's Range: 99.44 - 102.30 | GILD Avg Daily Volume: 15,570,600
Last Update: 11/24/14 - 4:00 PM EST
Volume: 17,080,325
YTD Performance: 33.93%
Open: $101.11
Previous Close: $100.58
52 Week Range: $63.50 - $116.83
Oustanding Shares: 1,508,664,333
Market Cap: 151,756,545,256
6-Month Chart
TheStreet Ratings Grade for GILD
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 12 12 12 12
Moderate Buy 2 2 1 1
Hold 3 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.47 1.38 1.33 1.33
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 17.84
Price Earnings Comparisons:
GILD Sector Avg. S&P 500
17.84 17.80 25.70
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-1.65% 40.42% 454.77%
GROWTH 12 Mo 3 Yr CAGR
Revenue 15.50 0.41 0.12
Net Income 18.80 0.06 0.02
EPS 10.80 0.18 0.06
Earnings for GILD:
EBITDA 4.87B
Revenue 11.20B
Average Earnings Estimates
Qtr (12/14) Qtr (03/15) FY (12/14) FY (12/15)
Average Estimate $2.34 $3.49 $7.93 $10.82
Number of Analysts 2 1 2 2
High Estimate $2.36 $3.49 $7.94 $11.88
Low Estimate $2.32 $3.49 $7.91 $9.76
Prior Year $0.52 $1.44 $1.92 $7.93
Growth Rate (Year over Year) 350.00% 142.36% 312.76% 36.53%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands

Buy Gilead Sciences Real Money Pro($)

Its prospects exploded with a breakthrough drug.
Gilead and YY are poised for potential climbs.

Gilead Down Real Money Pro($)

On Hep C data.
Investors are seeing growth today in three areas.
Beat the short-term crown in these three areas for the long term.
As these examples illustrate, it's just good risk management.

Invest in a Healthy Liver Real Money Pro($)

Drugs for liver diseases are good opportunities.
Still, it's a good time to review what's happening, so we never forget.
The Fed event can actually be good for many stocks.

This Morning's Market Setup Real Money Pro($)

Where it began.

Columnist Conversations

Market starts the week with all indices ending up as the S&P posts 46th new high of the year. Apple (AAPL...
Shares of Exxon Mobil (XOM) have formed multiple basing patterns on the daily chart over the last two months, ...
Conclusion BBRY stock is up 67% in the last year. The stock is also down 95% from its all-time highs. I'm go...
$PANW delivers a perfect number but it might not be enough!!expensive...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.